[1]
Bernardino, R. et al. 2023. Using active surveillance for Gleason 7 (3+4) prostate cancer: A narrative review. Canadian Urological Association Journal. 18, 4 (Dec. 2023), 135–44. DOI:https://doi.org/10.5489/cuaj.8539.